U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Tue Apr 01 20:23:34 GMT 2025
Edited
by admin
on Tue Apr 01 20:23:34 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
Z7HVY03PHP
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
MIRIKIZUMAB
USAN  
USAN   INN  
Official Name English
LY-3074828
Preferred Name English
LY3074828
Code English
MIRIKIZUMAB [USAN]
Common Name English
mirikizumab [INN]
Common Name English
MIRIKIZUMAB [JAN]
Common Name English
Mirikizumab [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 577817
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
FDA ORPHAN DRUG 584617
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
Code System Code Type Description
DAILYMED
Z7HVY03PHP
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
FDA UNII
Z7HVY03PHP
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
NCI_THESAURUS
C170182
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
USAN
DE-114
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
CAS
1884201-71-1
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
SMS_ID
300000025307
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
INN
10657
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
DRUG BANK
DB14910
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
WIKIPEDIA
Mirikizumab
Created by admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
PRIMARY
From To
1_22 1_96
1_129 3_214
1_142 1_198
1_221 2_221
1_224 2_224
1_256 1_316
1_362 1_420
2_22 2_96
2_129 4_214
2_142 2_198
2_256 2_316
2_362 2_420
3_23 3_88
3_134 3_194
4_23 4_88
4_134 4_194
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_292
N 2_292
Related Record Type Details
TARGET -> INHIBITOR
SUB_CONCEPT->SUBSTANCE
Related Record Type Details
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO_ACID_SUBSTITUTION [1_1] [2_1] N-TERMINUS PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL